Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-Adenosyl Methionine for HCC Recurrence
NCT02586285Phase 1Unknown
- Sponsor
- Eastern Hepatobiliary Surgery Hospital
- Start
- Jun 2015
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of S-adenosylmethionine in hepatocellular carcinoma (HCC) (2 arms), sponsored by Eastern Hepatobiliary Surgery Hospital. Primary endpoint: Time to tumor recurrence at 5 years. Status: unknown.
02
Drugs
S-adenosylmethionine
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT02586285.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02586285.